Chunpeng Yu
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Tislelizumab plus tyrosine kinase inhibitors with TACE improves survival in unresectable hepatocellular carcinoma with clinical predictors and manageable safety.
Journal: Frontiers in immunology
Published: July 12, 2025
Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Journal: Radiology and oncology
Published: June 01, 2023
Latrogenic Cerebral Infarction: A Rare but Sever Complication Caused by Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma.
Journal: Cardiovascular and interventional radiology
Published: May 16, 2023
Hepatitis B virus (HBV) codon adapts well to the gene expression profile of liver cancer: an evolutionary explanation for HBV's oncogenic role.
Journal: Journal of microbiology (Seoul, Korea)
Published: August 16, 2022
Astragalus polysaccharides alleviates cardiac hypertrophy in diabetic cardiomyopathy via inhibiting the BMP10-mediated signaling pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 12, 2021
Effect of microRNA-133a-3p/matrix metalloproteinase-9 axis on the growth of atherosclerotic vascular smooth muscle cells.
Journal: Experimental and therapeutic medicine
Published: November 21, 2018
MicroRNA-199a-5p aggravates primary hypertension by damaging vascular endothelial cells through inhibition of autophagy and promotion of apoptosis.
Journal: Experimental and therapeutic medicine
Published: October 07, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026